Tue.Oct 26, 2021

article thumbnail

It’s time to get back to basics in DTC marketing

World of DTC Marketing

LEAD-IN: “What is the reason to believe?” It seems like a simple question, doesn’t it yet? In today’s micro-segmented audience environment, it’s often hard to come up with one reason that might resonate with everyone in your target audience. I’ve noticed a trend that’s been emerging in the last couple of years.

Marketing 199
article thumbnail

Why Your Company’s Coaching Efforts Are Failing

Integrity Solutions

With the stakes higher than ever, organizations recognize that coaching plays a critical role in engaging employees, reducing turnover and improving overall business performance. So why are most of their coaching efforts failing? In the face of competing business priorities, increased workloads and broader responsibilities, every leader is feeling the pressure.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

While COVID-19 has brought health inequities to the forefront, they have persisted in America for decades, from clinical research to the point of care. To advance equity in clinical research, the U.S. Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry.

article thumbnail

IP maintenance – a hidden priority

Clarivate

IP strategy is intrinsically linked to business strategy. Likewise, while intangible, IP assets – including patents and trademarks – are indispensable business assets. With so much time, effort and investment required in developing valuable IP, it is vital to make sure these rights are in the safest possible hands for their maintenance and protection.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

While COVID-19 has brought health inequities to the forefront, they have persisted in America for decades, from clinical research to the point of care. To advance equity in clinical research, the U.S. Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial [.].